MUC1 aptamer-capped mesoporous silica nanoparticles for controlled drug delivery and radio-imaging applications

Fecha de publicación:

Autores de CIPF

Participantes ajenos a CIPF

  • Pascual, L
  • Cerqueira-Coutinho, C
  • de Luis, B
  • Bernardes, ES
  • Albernaz, MS
  • Missailidis, S
  • Santos-Oliveira, R

Grupos de Investigación

Abstract

Mucin 1 (MUC1) is a cell surface protein overexpressed in breast cancer. Mesoporous silica nanoparticles (MSNs) loaded with safranin O, functionalized with aminopropyl groups and gated with the negatively charged MUC1 aptamer have been prepared (S1-apMUC1) for specific targeting and cargo release in tumoral versus non-tumoral cells. Confocal microscopy studies showed that the S1-apMUC1 nanoparticles were internalized in MDA-MB-231 breast cancer cells that overexpress MUC1 receptor with subsequent pore opening and cargo release. Interestingly, the MCF-10-A non-tumorigenic breast epithelial cell line that do not overexpress MUC1, showed reduced (S1-apMUC1) internalization. Negligible internalization was also found for S1-ap nanoparticles that contained a scrambled DNA sequence as gatekeeper. S2-apMUC1 nanoparticles (similar to S1-apMUC1 but loaded with doxorubicin) internalized in MDA-MB-231 cells and induced a remarkable reduction in cell viability. Moreover, S1-apMUC1 nanoparticles radio-labeled with Tc-99m (S1-apMUC1-Tc) showed a remarkable tumor targeting in in vivo studies with MDA-MB-231 tumor-bearing Balb/c mice. (C) 2017 Elsevier Inc. All rights reserved.

Datos de la publicación

ISSN/ISSNe:
1549-9634, 1549-9642

NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE  ELSEVIER SCIENCE BV

Tipo:
Article
Páginas:
2495-2505
PubMed:
28842375

Citas Recibidas en Web of Science: 90

Documentos

  • No hay documentos

Métricas

Filiaciones mostrar / ocultar

Keywords

  • Radiopharmaceuticals; Nanotechnology; Oncology; Mesoporous silica nanoparticles

Proyectos asociados

Exploiting Protein Complexes that induce Cell-death

Investigador Principal: MARIA MAR ORZÁEZ CALATAYUD

COMMISSION OF EUROPEAN COMMUNITIES . 2016

Red de Transtornos Adictivos

Investigador Principal: CONSUELO GUERRI SIRERA

INSTITUTO DE SALUD CARLOS III . 2017

Compartir